Transgene SA TRGNF
Set alert
0.75 USD 0.00 0.00%
At close · Oct 30
0.80 Day range 0.80
0.70 52-week range 1.08
- YTD
- -25.50%
- 1 year
- +6.43%
- Open
- 0.80
- Prev close
- 0.745
- Mkt cap
- 207.30M
- Vol
- 1.00K
- Avg vol
- 26
- EPS
- -0.20
- P/E
- 0.00
More statistics
- Low
- 0.80
- High
- 0.80
News
- Transgene SA (TRGNF) Discusses Progress in Individualized Neoantigen Therapeutic Vaccines and Expansion into Early-Stage NSCLC Transcript
- Transgene SA (TRGNF) Q4 2025 Earnings Call Transcript
- Transgene announces the resume of trading of its shares on Euronext Paris as of the opening of the markets
- Correction: Transgene Announces the Temporary Suspension of Trading of its Shares on Euronext Paris
- Transgene Announces the Temporary Suspension of Trading of its Shares on Euronext Paris
- Transgene SA (TRGNF) Discusses TG4050 Phase I Immunological Data in Head and Neck Cancer from SITC Presentation Transcript
- Transgene and BioInvent's Armed Oncolytic Virus BT-001 Shows Positive Local, Abscopal, and Sustained Antitumoral Activity in Advanced Refractory Tumors
- Transgene and BioInvent's Armed Oncolytic Virus BT-001 Shows Positive Local, Abscopal, and Sustained Antitumoral Activity in Advanced Refractory Tumors
- Transgene and BioInvent to Present Translational Data and Updated Clinical Results on Armed Oncolytic Virus BT-001, at ESMO 2025
- Transgene and BioInvent to Present Translational Data and Updated Clinical Results on Armed Oncolytic Virus BT-001, at ESMO 2025
Your note
Sign in to keep a note on TRGNF — it syncs with the Stock Master app.